Clinical infection control in gene therapy

A multidisciplinary conference

M. E. Evans, C. T. Jordan, S. M W Chang, C. Conrad, J. L. Gerberding, H. L. Kaufman, C. G. Mayhall, J. A. Nolta, A. M. Pilaro, S. Sullivan, D. J. Weber, N. A. Wivel

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Gene therapy is being studied for the treatment of a variety of acquired and inherited disorders. Retroviruses, adenoviruses, poxviruses, adeno-associated viruses, herpesviruses, and others are being engineered to transfer genes into humans. Treatment protocols using recombinant viruses are being introduced into clinical settings. Infection control professionals will be involved in reviewing the safety of these agents in their clinics and hospitals. To date, only a limited number of articles have been written on infection control in gene therapy,1,2 and no widely available recommendations exist from federal or private organizations to guide infection control professionals. The goals of the conference were to provide a forum where gene therapy experts could share their perspectives and experience with infection control in gene therapy and to provide an opportunity for newcomers to the field to learn about issues specific to infection control in gene therapy. Recommendations for infection control in gene therapy were proposed.

Original languageEnglish (US)
Pages (from-to)659-673
Number of pages15
JournalInfection Control and Hospital Epidemiology
Volume21
Issue number10
StatePublished - 2000

Fingerprint

Infection Control
Genetic Therapy
Poxviridae
Dependovirus
Herpesviridae
Retroviridae
Clinical Protocols
Adenoviridae
Viruses
Safety
Genes

ASJC Scopus subject areas

  • Immunology
  • Microbiology (medical)

Cite this

Evans, M. E., Jordan, C. T., Chang, S. M. W., Conrad, C., Gerberding, J. L., Kaufman, H. L., ... Wivel, N. A. (2000). Clinical infection control in gene therapy: A multidisciplinary conference. Infection Control and Hospital Epidemiology, 21(10), 659-673.

Clinical infection control in gene therapy : A multidisciplinary conference. / Evans, M. E.; Jordan, C. T.; Chang, S. M W; Conrad, C.; Gerberding, J. L.; Kaufman, H. L.; Mayhall, C. G.; Nolta, J. A.; Pilaro, A. M.; Sullivan, S.; Weber, D. J.; Wivel, N. A.

In: Infection Control and Hospital Epidemiology, Vol. 21, No. 10, 2000, p. 659-673.

Research output: Contribution to journalArticle

Evans, ME, Jordan, CT, Chang, SMW, Conrad, C, Gerberding, JL, Kaufman, HL, Mayhall, CG, Nolta, JA, Pilaro, AM, Sullivan, S, Weber, DJ & Wivel, NA 2000, 'Clinical infection control in gene therapy: A multidisciplinary conference', Infection Control and Hospital Epidemiology, vol. 21, no. 10, pp. 659-673.
Evans ME, Jordan CT, Chang SMW, Conrad C, Gerberding JL, Kaufman HL et al. Clinical infection control in gene therapy: A multidisciplinary conference. Infection Control and Hospital Epidemiology. 2000;21(10):659-673.
Evans, M. E. ; Jordan, C. T. ; Chang, S. M W ; Conrad, C. ; Gerberding, J. L. ; Kaufman, H. L. ; Mayhall, C. G. ; Nolta, J. A. ; Pilaro, A. M. ; Sullivan, S. ; Weber, D. J. ; Wivel, N. A. / Clinical infection control in gene therapy : A multidisciplinary conference. In: Infection Control and Hospital Epidemiology. 2000 ; Vol. 21, No. 10. pp. 659-673.
@article{0cb39742209f4251a9364d461b5d0295,
title = "Clinical infection control in gene therapy: A multidisciplinary conference",
abstract = "Gene therapy is being studied for the treatment of a variety of acquired and inherited disorders. Retroviruses, adenoviruses, poxviruses, adeno-associated viruses, herpesviruses, and others are being engineered to transfer genes into humans. Treatment protocols using recombinant viruses are being introduced into clinical settings. Infection control professionals will be involved in reviewing the safety of these agents in their clinics and hospitals. To date, only a limited number of articles have been written on infection control in gene therapy,1,2 and no widely available recommendations exist from federal or private organizations to guide infection control professionals. The goals of the conference were to provide a forum where gene therapy experts could share their perspectives and experience with infection control in gene therapy and to provide an opportunity for newcomers to the field to learn about issues specific to infection control in gene therapy. Recommendations for infection control in gene therapy were proposed.",
author = "Evans, {M. E.} and Jordan, {C. T.} and Chang, {S. M W} and C. Conrad and Gerberding, {J. L.} and Kaufman, {H. L.} and Mayhall, {C. G.} and Nolta, {J. A.} and Pilaro, {A. M.} and S. Sullivan and Weber, {D. J.} and Wivel, {N. A.}",
year = "2000",
language = "English (US)",
volume = "21",
pages = "659--673",
journal = "Infection Control and Hospital Epidemiology",
issn = "0899-823X",
publisher = "University of Chicago Press",
number = "10",

}

TY - JOUR

T1 - Clinical infection control in gene therapy

T2 - A multidisciplinary conference

AU - Evans, M. E.

AU - Jordan, C. T.

AU - Chang, S. M W

AU - Conrad, C.

AU - Gerberding, J. L.

AU - Kaufman, H. L.

AU - Mayhall, C. G.

AU - Nolta, J. A.

AU - Pilaro, A. M.

AU - Sullivan, S.

AU - Weber, D. J.

AU - Wivel, N. A.

PY - 2000

Y1 - 2000

N2 - Gene therapy is being studied for the treatment of a variety of acquired and inherited disorders. Retroviruses, adenoviruses, poxviruses, adeno-associated viruses, herpesviruses, and others are being engineered to transfer genes into humans. Treatment protocols using recombinant viruses are being introduced into clinical settings. Infection control professionals will be involved in reviewing the safety of these agents in their clinics and hospitals. To date, only a limited number of articles have been written on infection control in gene therapy,1,2 and no widely available recommendations exist from federal or private organizations to guide infection control professionals. The goals of the conference were to provide a forum where gene therapy experts could share their perspectives and experience with infection control in gene therapy and to provide an opportunity for newcomers to the field to learn about issues specific to infection control in gene therapy. Recommendations for infection control in gene therapy were proposed.

AB - Gene therapy is being studied for the treatment of a variety of acquired and inherited disorders. Retroviruses, adenoviruses, poxviruses, adeno-associated viruses, herpesviruses, and others are being engineered to transfer genes into humans. Treatment protocols using recombinant viruses are being introduced into clinical settings. Infection control professionals will be involved in reviewing the safety of these agents in their clinics and hospitals. To date, only a limited number of articles have been written on infection control in gene therapy,1,2 and no widely available recommendations exist from federal or private organizations to guide infection control professionals. The goals of the conference were to provide a forum where gene therapy experts could share their perspectives and experience with infection control in gene therapy and to provide an opportunity for newcomers to the field to learn about issues specific to infection control in gene therapy. Recommendations for infection control in gene therapy were proposed.

UR - http://www.scopus.com/inward/record.url?scp=0033786583&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033786583&partnerID=8YFLogxK

M3 - Article

VL - 21

SP - 659

EP - 673

JO - Infection Control and Hospital Epidemiology

JF - Infection Control and Hospital Epidemiology

SN - 0899-823X

IS - 10

ER -